AN2 Therapeutics Inc.

NASDAQ: ANTX · Real-Time Price · USD
1.10
0.05 (4.27%)
At close: Aug 15, 2025, 3:59 PM
1.11
0.78%
After-hours: Aug 15, 2025, 07:15 PM EDT

AN2 Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.8 -7.47 -3.57 -13.4
PEG Ratio
0.02 4.17 -0.04 -0.15
PS Ratio
n/a n/a n/a n/a
PB Ratio
0.50 3.88 1.53 4.66
P/FCF Ratio
-0.84 -9.07 -4.37 -14.09
P/OCF Ratio
-0.84 -9.07 -4.37 -14.09
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
n/a n/a 0.00 n/a
Quick Ratio
8.43 7.87 13.72 17.70
Current Ratio
8.43 7.87 13.72 17.70
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a n/a -82.22 n/a
Return on Equity
-0.63 -0.52 -0.43 -0.35
Return on Assets
-0.56 -0.47 -0.4 -0.33
Return on Invested Capital
-0.67 -0.56 -0.44 -0.35
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a